TotalMarketCap

Abeona Therapeutics

ABEONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$224.447 M

$3.93 -6.99%

Close of 6 Nov 2026

As of 6 Nov 2026, Abeona Therapeutics (ABEO) has a market capitalization of $224.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$5.82M

#3239 by revenue

Earnings

-$71.2M

Loss-making

Shares outstanding

57,184,017

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #235Amarin Corp PlcukAMRN$238.3M
  2. #236Camp4 TherapeuticsCAMP$233.4M
  3. #237Abeona TherapeuticsABEO$224.4M
  4. #238Korro BioKRRO$219.3M
  5. #239ImmuneeringIMRX$217.9M

What if Abeona Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$493,789.62

Per share 125,806× higher

Bitcoin $1.53T

$26,718.10

Per share 6,807× higher

Apple $5.02T

$87,713.02

Per share 22,347× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Abeona Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.